Blaine Labs, Inc Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contamination
Potential infection risk for vulnerable patients highlights critical quality system considerations
Recall Overview
Blaine Labs, Inc. has issued a voluntary nationwide recall of select lots of antiseptic wound care gel products due to microbial contamination.
Company: Blaine Labs, Inc.
Brand Names: Revitaderm®, Tridergel™
Product Type: Drug (Topical antiseptic)
FDA Publish Date: April 8, 2026
Reason: Presence of Lysinibacillus fusiformis
Affected Products
Affected products were distributed nationwide to healthcare providers (non-retail).
Revitaderm® Wound Care Antiseptic Gel (1 oz. & 3 oz.)
Active Ingredient: Benzalkonium Chloride 0.1%
Affected lots:
- BL3608 (Exp. 07/01/28)
- BL3435 (Exp. 11/06/26)
- BL3525 (Exp. 08/07/27)
Tridergel™ Wound Care (1 oz.)
Active Ingredient: Benzalkonium Chloride 0.1%
Affected lot: BL3435 (Exp. 11/06/26)
Risk Assessment
The contamination involves Lysinibacillus fusiformis, a spore-forming environmental organism. While generally low risk for healthy individuals, the risk profile changes significantly for patients with open wounds, diabetic patients, elderly individuals, and immunocompromised populations.
Potential outcomes include local infection, skin irritation, delayed wound healing, and severe complications (rare), that include endocarditis, a central nervous system infection.
Clinical Context
This recall is particularly notable because the product is intended to prevent infection. Contamination in this context represents a reversal of intended function, increasing risk rather than mitigating it.
MDP Regulatory and Quality Insight
This event highlights several critical areas of concern.
Microbiological Control in Non-Sterile Drug Products
Even though these are non-sterile topical products, they must meet microbial limits and have an absence of objectionable organisms.
The presence of a spore-forming organism suggests potential gaps in environmental control, inadequate preservative effectiveness, and possible manufacturing or packaging contamination pathways.
Risk-Based Product Use Consideration
Topical antiseptics that are used on broken skin or other compromised tissue functionally behave like higher-risk products. This raises the question of whether certain “non-sterile” products be tested with enhanced microbial controls?
Distribution Channel Risk
Products were distributed to physician offices and other clinical settings. This increases risk because product use is likely on vulnerable patient populations where traceability and recall effectiveness become critical.
CAPA and Root Cause Expectations
Regulators will expect a full root cause investigation, to include an evaluation of water systems, raw materials, environmental monitoring, and packaging integrity.
What Healthcare Providers Should Do
Healthcare providers who have these products should immediately identify and segregate affected lots, discontinue use and distribution, and contact Blaine Labs for return instructions.
Adverse Events
To date, no adverse events have been reported. However, given the risk population, monitoring is warranted.
MDP Perspective
This recall underscores a critical principle, that product classification does not always reflect real-world risk. A “non-sterile” topical product that is applied to compromised tissue, especially in vulnerable populations, can present risks closer to those of sterile products if contamination occurs.
Key Takeaways for Manufacturers
Manufacturers of topical products should reevaluate microbial control strategies, strengthen environmental monitoring programs, validate preservative systems rigorously, and consider risk-based escalation of controls for wound care products.
Contact Information
Blaine Labs, Inc.
📞 (800) 307-8818
📧 Contact@blainelabs.com
Links
Read the FDA’s announcement here.
One Contaminated Alcohol Pad, Multiple Recalls
A Lesson in Medical Device Supply Chain Quality At first glance, Cardinal Health's recent recall of Webcol™ Alcohol Prep Pads appears straightforward. A commonly used healthcare product was found to be contaminated with Paenibacillus phoenicis, creating a potential...
Early Alert: Windstone Medical Recall for Convenience Kits
FDA Warns of Convenience Kits Containing Recalled Cardinal Health Alcohol Pads The FDA has issued an Early Alert regarding several medical convenience kits distributed by Windstone Medical Packaging, Inc. that contain alcohol prep pads previously recalled by Cardinal...
Webcol Alcohol Prep Pads Recall Due to Microbial Contamination
Cardinal Health Recalls Alcohol Prep Pads Over Infection Risk Concerns Cardinal Health has issued a voluntary nationwide recall of select lots of its Webcol™ Large Alcohol Prep Pads (70% isopropyl alcohol) after testing identified microbial contamination with...
FDA Issues Warning Letter for Modifications to Infant Products
FDA Issues Warning Letter to Happiest Baby Over SNOO Smart Sleeper Modifications and Quality System Deficiencies The U.S. Food and Drug Administration has issued a Warning Letter to Happiest Baby, Inc., manufacturer of the SNOO Smart Sleeper, citing unapproved device...
FDA Expands Draeger Atlan Anesthesia Workstation Correction
More anesthesia machines added to correction for potential ventilation failure The U.S. Food and Drug Administration (FDA) has designated a recent expansion of Draeger, Inc.'s Atlan anesthesia workstation correction as a Class I recall, the agency's most serious...
Warning Letter to Zoll Medical for Major QMS Violations
Warning Letter to Zoll Medical for Major QMS Violations The U.S. Food and Drug Administration has issued a Warning Letter to ZOLL Medical Corporation citing significant Quality System Regulation (QSR) violations involving corrective and preventive action (CAPA),...
